These findings are consistent with those of other studies, such as that of Hasegawa et al. [18], who analyzed 48 patients with RA and found an improvement in total lean mass and a reduction in the percentage of patients with sarcopenia after 12 months of treatment with TNF inhibitors. This evidence concerns the gene TNF and sarcopenia.